rs1800847
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_021784.5(FOXA2):c.309C>T(p.Ala103Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0502 in 1,528,470 control chromosomes in the GnomAD database, including 3,153 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.080 ( 733 hom., cov: 33)
Exomes 𝑓: 0.047 ( 2420 hom. )
Consequence
FOXA2
NM_021784.5 synonymous
NM_021784.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.643
Genes affected
FOXA2 (HGNC:5022): (forkhead box A2) This gene encodes a member of the forkhead class of DNA-binding proteins. These hepatocyte nuclear factors are transcriptional activators for liver-specific genes such as albumin and transthyretin, and they also interact with chromatin. Similar family members in mice have roles in the regulation of metabolism and in the differentiation of the pancreas and liver. This gene has been linked to sporadic cases of maturity-onset diabetes of the young. Transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 20-22582933-G-A is Benign according to our data. Variant chr20-22582933-G-A is described in ClinVar as [Benign]. Clinvar id is 1569424.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.643 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.157 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXA2 | NM_021784.5 | c.309C>T | p.Ala103Ala | synonymous_variant | 2/2 | ENST00000419308.7 | NP_068556.2 | |
FOXA2 | NM_153675.3 | c.291C>T | p.Ala97Ala | synonymous_variant | 3/3 | NP_710141.1 | ||
FOXA2 | XM_047440133.1 | c.291C>T | p.Ala97Ala | synonymous_variant | 3/3 | XP_047296089.1 | ||
FOXA2 | XM_047440134.1 | c.201C>T | p.Ala67Ala | synonymous_variant | 2/2 | XP_047296090.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXA2 | ENST00000419308.7 | c.309C>T | p.Ala103Ala | synonymous_variant | 2/2 | 1 | NM_021784.5 | ENSP00000400341.3 | ||
FOXA2 | ENST00000377115.4 | c.291C>T | p.Ala97Ala | synonymous_variant | 3/3 | 1 | ENSP00000366319.4 |
Frequencies
GnomAD3 genomes AF: 0.0799 AC: 12133AN: 151914Hom.: 727 Cov.: 33
GnomAD3 genomes
AF:
AC:
12133
AN:
151914
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0712 AC: 9347AN: 131320Hom.: 517 AF XY: 0.0710 AC XY: 5194AN XY: 73146
GnomAD3 exomes
AF:
AC:
9347
AN:
131320
Hom.:
AF XY:
AC XY:
5194
AN XY:
73146
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0469 AC: 64568AN: 1376450Hom.: 2420 Cov.: 35 AF XY: 0.0481 AC XY: 32709AN XY: 680274
GnomAD4 exome
AF:
AC:
64568
AN:
1376450
Hom.:
Cov.:
35
AF XY:
AC XY:
32709
AN XY:
680274
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0800 AC: 12161AN: 152020Hom.: 733 Cov.: 33 AF XY: 0.0792 AC XY: 5888AN XY: 74322
GnomAD4 genome
AF:
AC:
12161
AN:
152020
Hom.:
Cov.:
33
AF XY:
AC XY:
5888
AN XY:
74322
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
508
AN:
3452
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
FOXA2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 17, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at